sk&f 97541 has been researched along with lesogaberan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alstermark, C; Amin, K; Dinn, SR; Elebring, T; Fitzpatrick, K; Fjellström, O; Geiss, WB; Gottfries, J; Guzzo, PR; Harding, JP; Holmén, A; Kothare, M; Lehmann, A; Mattsson, JP; Nilsson, K; Sundén, G; Swanson, M; von Unge, S; Woo, AM; Wyle, MJ; Zheng, X | 1 |
| Annamalai, T; Chen, JL; Chernov-Rogan, T; Dilip, U; Gallop, MA; Grindstaff, K; Koller, K; Peng, G; Phan, T; Wustrow, DJ; Xu, F; Zhang, X | 1 |
2 other study(ies) available for sk&f 97541 and lesogaberan
| Article | Year |
|---|---|
Synthesis and pharmacological evaluation of novel gamma-aminobutyric acid type B (GABAB) receptor agonists as gastroesophageal reflux inhibitors.
Topics: Animals; Dose-Response Relationship, Drug; GABA Agonists; GABA-B Receptor Agonists; Gastroesophageal Reflux; Humans; Magnetic Resonance Spectroscopy; Spectrometry, Mass, Fast Atom Bombardment | 2008 |
Discovery of a novel potent GABA(B) receptor agonist.
Topics: Animals; Baclofen; Blood-Brain Barrier; Drug Discovery; GABA Agonists; Humans; Mice; Receptors, GABA-B | 2011 |